CHE · 10-Q · 2026Q1 · Full report

Procedure Volume Trends

CHEMED CORP · 2026-04-28 · Importance 31 · Surprise 32

VITAS reported total days of care of 2,045,074 in Q1 2026, up 2.2% versus 2,001,996 in Q1 2025, driven by routine homecare days increasing 3.6% to 1,691,619. Inpatient and continuous care patterns shifted: general inpatient days rose 2.6% while continuous care days declined significantly (23.6% decline in continuous care days). Total admissions increased to 19,394 from 18,139, and average daily census rose modestly reflecting higher utilization of homecare services. The hospice segment therefore experienced modest volume growth overall but notable declines in higher-acuity continuous care days.

Key facts

• VITAS nursing home days for the three months ended March 31, 2026: 294,818 days (4.0% decrease versus prior year)
• VITAS routine homecare days for the three months ended March 31, 2026: 1,691,619 days (3.6% increase versus prior year)
• Total admissions for VITAS for the three months ended March 31, 2026: 19,394 versus 18,139 prior year
• Total discharges for VITAS for the three months ended March 31, 2026: 18,537 versus 17,875 prior year
• VITAS days of care total for the three months ended March 31, 2026: 2,045,074 days (2.2% increase versus 2,001,996 prior year)
• Average length of stay for VITAS for the three months ended March 31, 2026: 102.7 days versus 118.7 days prior year
• VITAS respite days for the three months ended March 31, 2026: 10,875 days (8.8% increase versus prior year)
• Average daily census (ADC) total for VITAS in the three months ended March 31, 2026: 22,723 days versus 22,244 prior year